haloperidol has been researched along with dexoxadrol in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frehland, B; Schepmann, D; Schmidtke, KU; Tewes, B; Winckler, T; Wünsch, B | 1 |
| Bergander, K; Fabian, J; Köhler, J; Schepmann, D; Wünsch, B | 1 |
| Bourgeois, C; Christoph, T; Englberger, W; Galla, F; Galla, HJ; Hüwel, S; Kögel, B; Lehmkuhl, K; Schepmann, D; Soeberdt, M; Straßburger, W; Torres-Gómez, H; Werfel, E; Wünsch, B | 1 |
| Bonifazi, A; Gawaskar, S; Schepmann, D; Wünsch, B | 1 |
| Bonifazi, A; Gawaskar, S; Robaa, D; Schepmann, D; Sippl, W; Wünsch, B | 1 |
| Dey, S; Schepmann, D; Wünsch, B | 2 |
| Dey, S; Frehland, B; Lehmkuhl, K; Schepmann, D; Schreiber, JA; Seebohm, G; Strutz-Seebohm, N; Temme, L; Wünsch, B | 1 |
| Rath, S; Schepmann, D; Wünsch, B | 1 |
| Kitamura, M; Schepmann, D; Shuto, Y; Temme, L; Thum, S; Wünsch, B | 1 |
| Ametamey, SM; Schepmann, D; Wagner, M; Wünsch, B | 1 |
11 other study(ies) available for haloperidol and dexoxadrol
| Article | Year |
|---|---|
Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diols.
Topics: Analgesics; Animals; Benzazepines; Humans; Mice; Microsomes, Liver; Neuralgia; Piperidines; Rats; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2010 |
Enantiomerically pure 1,3-dioxanes as highly selective NMDA and σ₁ receptor ligands.
Topics: Animals; Benzylamines; Binding Sites; Binding, Competitive; Cerebral Cortex; Dioxanes; Ethylamines; Guinea Pigs; Ligands; Phencyclidine; Radioligand Assay; Receptors, N-Methyl-D-Aspartate; Receptors, sigma; Stereoisomerism; Swine | 2012 |
Synthesis and pharmacological evaluation of 5-pyrrolidinylquinoxalines as a novel class of peripherally restricted κ-opioid receptor agonists.
Topics: Analgesics, Opioid; Animals; Binding, Competitive; Blood-Brain Barrier; Brain; Endothelial Cells; Guinea Pigs; HEK293 Cells; Humans; Liver; Male; Mice; Models, Molecular; Pain Measurement; Permeability; Pyrrolidines; Quinoxalines; Radioligand Assay; Rats; Receptors, N-Methyl-D-Aspartate; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Receptors, sigma; Stereoisomerism; Structure-Activity Relationship | 2014 |
Synthesis, GluN2B affinity and selectivity of benzo[7]annulen-7-amines.
Topics: Benzocycloheptenes; Dose-Response Relationship, Drug; Humans; Molecular Structure; Piperazines; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2014 |
Benzo[7]annulene-based GluN2B selective NMDA receptor antagonists: Surprising effect of a nitro group in 2-position.
Topics: Amines; Binding Sites; Molecular Docking Simulation; Phenols; Piperidines; Protein Binding; Protein Structure, Tertiary; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2015 |
Role of the phenolic OH moiety of GluN2B-selective NMDA antagonists with 3-benzazepine scaffold.
Topics: Benzazepines; Binding Sites; Humans; Kinetics; Molecular Docking Simulation; Phenols; Piperidines; Protein Structure, Tertiary; Receptors, N-Methyl-D-Aspartate; Tritium | 2016 |
Deconstruction - reconstruction approach to analyze the essential structural elements of tetrahydro-3-benzazepine-based antagonists of GluN2B subunit containing NMDA receptors.
Topics: Benzazepines; Dose-Response Relationship, Drug; Humans; Models, Molecular; Molecular Structure; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2017 |
Replacement of benzylic hydroxy group by vinyl or hydroxymethyl moiety at the 3-benzazepine scaffold retaining GluN2B affinity.
Topics: Benzazepines; Dose-Response Relationship, Drug; Humans; Molecular Structure; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2017 |
2-Methyltetrahydro-3-benzazepin-1-ols - The missing link in SAR of GluN2B selective NMDA receptor antagonists.
Topics: Benzazepines; Dose-Response Relationship, Drug; Humans; Molecular Docking Simulation; Molecular Structure; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2018 |
Do GluN2B subunit containing NMDA receptors tolerate a fluorine atom in the phenylalkyl side chain?
Topics: | 2017 |
Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.
Topics: Benzazepines; Binding Sites; Models, Molecular; Receptors, N-Methyl-D-Aspartate; Structure-Activity Relationship | 2019 |